CUSIP 019770106COMALLOQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
169 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Pfizer Inc | 22.03M | $30.18M | 0 | Held |
| 2 | Tpg Gp A, LLC | 18.72M | $25.64M | 0 | Held |
| 3 | Blackrock, Inc. | 17.68M | $24.22M | +161.4K | Added |
| 4 | Citadel Advisors LLC | 12.11M | $16.59M |
| Reduced |
| 5 | Vanguard Group Inc | 9.25M | $12.67M | +230.8K | Added |
| 6 | Primecap Management Co/Ca/ | 8.14M | $11.15M | +1.06M | Added |
| 7 | Patient Square Capital LP | 4.96M | $6.80M | +1.98M | Added |
| 8 | Geode Capital Management, LLC | 3.93M | $5.39M | +99.0K | Added |
| 9 | Frazier Life Sciences Management, L.P. | 3.87M | $5.30M | 0 | Held |
| 10 | Woodline Partners LP | 3.50M | $4.80M | −860.1K | Reduced |
See every fund holding Allogene Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders